Literature DB >> 17406944

Determination of the necessary total protein substitution requirements in patients with advanced stage ovarian cancer and ascites, undergoing debulking surgery. Correlation with plasma proteins.

George Vorgias1, Christos Iavazzo, John Mavromatis, Joanna Leontara, Michael Katsoulis, Nickolas Kalinoglou, Thrassivoulos Akrivos.   

Abstract

BACKGROUND: Ascites is common in patients with advanced ovarian carcinoma (AOC). Its drainage during surgery affects plasma proteins. We sought to correlate the volume of ascites with the oncological parameters of the disease, calculate its drainage effect on plasma proteins, and determine the necessary substitution requirements and a clinical way of achieving that. PATIENTS AND METHODS: We evaluated 138 patients with AOC and ascites who underwent primary cytoreductive surgery. Intraoperatively found ascites and its postoperative production were evaluated. Its drainage effect on plasma proteins and the substitution requirements were determined using a mathematic formula. Human albumin(HA) and fresh frozen plasma (FFP) were used to cover these requirements.
RESULTS: The intraoperative ascites was found to correlate only with the stage of the disease, while its postoperative production correlated with the residual disease. Optimally debulked patients had a mean ascites production of 128 mL on postoperative day 1 compared with 668 mL of the suboptimally debulked. This production required 3 and 5-7 days, respectively, to drop <50 mL. Plasma proteins fell on their minimum level (88.9 versus 80.8%) on the second postoperative day. The protein deficit was calculated to be 379 and 691 g/day, respectively. This deficit was substituted by administering 2 HA and 2 FFP for 3-6 days.
CONCLUSIONS: Ascites drainage affects the postoperative homeostasis of plasma proteins. A mean acute drop of 12-20% is monitored on postoperative day 2. This deficit can be managed with HA and FFP for a minimum of 3 days.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17406944     DOI: 10.1245/s10434-007-9404-x

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  11 in total

Review 1.  [Perioperative management for CRS and HIPEC : Anesthesiological aspects].

Authors:  D Bleiler; S Bleiler; B Sinner
Journal:  Chirurg       Date:  2018-09       Impact factor: 0.955

Review 2.  Intensive Care Management of Patient After Cytoreductive Surgery and HIPEC - A Concise Review.

Authors:  A V Padmakumar
Journal:  Indian J Surg Oncol       Date:  2016-02-18

Review 3.  [Perioperative management for CRS and HIPEC : Anesthesiological aspects].

Authors:  D Bleiler; S Bleiler; B Sinner
Journal:  Anaesthesist       Date:  2020-02       Impact factor: 1.041

4.  The effect of intraoperative fluid administration on outcomes of patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.

Authors:  Raphael Shamavonian; Rohan McLachlan; Oliver M Fisher; Sarah J Valle; Nayef A Alzahrani; Winston Liauw; David L Morris
Journal:  J Gastrointest Oncol       Date:  2019-04

5.  Post-operative critical care management of patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy (HIPEC).

Authors:  Timothy J Cooksley; Philip Haji-Michael
Journal:  World J Surg Oncol       Date:  2011-12-19       Impact factor: 2.754

6.  Cytoreductive onco-surgery with combined hyperthermic intraperitoneal chemotherapy and hyperthermic intrathoracic chemotherapy: Perioperative challenges.

Authors:  Rohini Dattatri; Rakesh Garg; Mukur Dipi Ray
Journal:  Saudi J Anaesth       Date:  2019 Apr-Jun

7.  Perioperative management and postoperative outcome of patients undergoing cytoreduction surgery with hyperthermic intraperitoneal chemotherapy.

Authors:  Hamed Elgendy; Hanaa Nafady-Hego; Hanan M Abd Elmoneim; Talha Youssef; Abdulaziz Alzahrani
Journal:  Indian J Anaesth       Date:  2019-10-10

8.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Fluid and temperature remain the culprit!

Authors:  Rakesh Garg
Journal:  Indian J Anaesth       Date:  2018-03

Review 9.  Anesthetic implications in hyperthermic intraperitoneal chemotherapy.

Authors:  Nishkarsh Gupta; Vinod Kumar; Rakesh Garg; Sachidanand Jee Bharti; Seema Mishra; Sushma Bhatnagar
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2019 Jan-Mar

10.  Hemodynamic Consequences of Malignant Ascites in Epithelial Ovarian Cancer Surgery*: A Prospective Substudy of a Randomized Controlled Trial.

Authors:  Oliver Hunsicker; Christina Fotopoulou; Klaus Pietzner; Mandy Koch; Alexander Krannich; Jalid Sehouli; Claudia Spies; Aarne Feldheiser
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.